News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

gel-e, Inc Expands Core Team With Regulatory, Manufacturing And Financial Talent



9/13/2017 9:52:40 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
- Key domain expertise added to grow gel-e's business

COLLEGE PARK, Md., Sept. 13, 2017 /PRNewswire/ -- gel-e Inc., a privately held, clinical-stage medical device company, announces the recent expansion of its core team, adding Elsa Abruzzo as Head of Regulatory, Bruce Choi as Head of Manufacturing, and Rich Vincent as the CFO.

 (PRNewsfoto/gel-e, Inc.)

Supported by its recent financing, the Company has been able to attract an experienced and talented group to support key corporate objectives: expanding gel-e's initial U.S. FDA regulatory clearance to a broader hemostatic product line for the treatment of external wounds, establishing cGMP manufacturing of gel-e's active ingredient, and preparing for the commercialization of its growing product line, see http://www.gel-e.co.

"Elsa, Bruce and Rich have already started making contributions as part of our expanded gel-e team," said Larry Tiffany, President and Director of gel-e. "Elsa has been instrumental in designing and implementing our regulatory strategy in order to expand our label claims for a variety of hemostatic products. Integrated into this strategy, Bruce is leading our core team to establish a manufacturing facility using a modular manufacturing approach that will support scale-up while ensuring we meet our quality, productivity and efficiency goals. Rich helped us close the recent equity round, and brings his expertise from many successful West Coast life science start-ups and commercial companies, including raising $650M in private and public financings, most recently for Genoa Pharmaceuticals." To learn more about each of their backgrounds, please visit http://www.gel-e.co/team.html.

About the Company
gel-e is developing a novel line of hemostatic and wound treatment products. With an initial focus on external wounds, gel-e combines the use of safe, inert ingredients with proprietary chemistry that can be designed for use across a broad spectrum of clinical applications, including vascular closure and during surgery. gel-e is based in College Park, Md.

For additional information, please visit http://www.gel-e.co.

Contacts:
Larry Tiffany, gel-e, Inc.
(301) 529-4943
pr@gel-e.co

View original content with multimedia:http://www.prnewswire.com/news-releases/gel-e-expands-core-team-with-regulatory-manufacturing-and-financial-talent-300518305.html

SOURCE gel-e, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES